1
|
Chen WQ, Zeng HM, Zheng RS, Zhang SW and
He J: Cancer incidence and mortality in China, 2007. Chin J Cancer
Res. 24:1–8. 2012. View Article : Google Scholar
|
2
|
Chang JT, Ko JY and Hong RL: Recent
advances in the treatment of nasopharyngeal carcinoma. J Formos Med
Assoc. 103:496–510. 2004.
|
3
|
Li L, Chen GG, Lu YN, Liu Y, Wu KF, Gong
XL, Gou ZP, Li MY and Liang NC:
Ent-11α-hydroxy-15-oxo-kaur-16-en-19-oic-acid inhibits the growth
of human lung cancer A549 cells by arresting cell cycle and
triggering apoptosis. Chin J Cancer Res. 24:109–115. 2012.
|
4
|
Vlantis AC, Lo CS, Chen GG, Ci Liang N,
Lui VW, Wu K, Deng YF, Gong X, Lu Y, Tong MC and van Hasselt CA:
Induction of laryngeal cancer cell death by
Ent-11-hydroxy-15-oxo-kaur-16-en-19-oic acid. Head Neck.
32:1506–1518. 2010. View Article : Google Scholar : PubMed/NCBI
|
5
|
Liu ZM, Chen GG, Vlantis AC, Liang NC,
Deng YF and van Hasselt CA: Cell death induced by
ent-11alpha-hydroxy-15-oxo-kaur-16-en-19-oic-acid in anaplastic
thyroid carcinoma cells is via a mitochondrial-mediated pathway.
Apoptosis. 10:1345–1356. 2005. View Article : Google Scholar : PubMed/NCBI
|
6
|
Liu Z, Ng EK, Liang NC, Deng YF, Leung BC
and Chen GG: Cell death induced by Pteris semipinnataL. is
associated with p53 and oxidant stress in gastric cancer cells.
FEBS Lett. 579:1477–1487. 2005.PubMed/NCBI
|
7
|
Chen GG, Liang NC, Lee JF, Chan UP, Wang
SH, Leung BC and Leung KL: Over-expression of Bcl-2 against
Pteris semipinnataL-induced apoptosis of human colon cancer
cells via a NF-kappa B-related pathway. Apoptosis. 9:619–627.
2004.PubMed/NCBI
|
8
|
Gu SY, Zhao WP, Zeng Y, Tang WP, Zhao ML,
Deng HH and Li K: New human nasopharyngeal epithelial cell line
established from a patient with poorly differentiated
nasopharyngeal carcinoma. Chin J Cancer. 2:70–72. 1983.
|
9
|
Deng YF and Liang NC: Study on extraction
and separation of diterpenoids from Pteris semipinnata. Chin
Pharm J. 39:742–744. 2004.
|
10
|
Sherr CJ: Cancer cell cycles. Science.
274:1672–1677. 1996. View Article : Google Scholar : PubMed/NCBI
|
11
|
Nigg EA: Cyclin-dependent protein kinases:
key regulators of the eukaryotic cell cycle. Bioessays. 17:471–480.
1995. View Article : Google Scholar : PubMed/NCBI
|
12
|
Gautier J, Solomon MJ, Booher RN, Bazan JF
and Kirschner MW: cdc25 is a specific tyrosine phosphatase that
directly activates p34cdc2. Cell. 67:197–211. 1991. View Article : Google Scholar : PubMed/NCBI
|
13
|
Jiang M, Wei Q, Pabla N, Dong G, Wang CY,
Yang T, Smith SB and Dong Z: Effects of hydroxyl radical scavenging
on cisplatin-induced p53 activation, tubular cell apoptosis and
nephrotoxicity. Biochem Pharmacol. 73:1499–1510. 2007. View Article : Google Scholar : PubMed/NCBI
|
14
|
Kim YH, Kim YW, Oh YJ, Back NI, Chung SA,
Chung HG, Jeong TS, Choi MS and Lee KT: Protective effect of the
ethanol extract of the roots of Brassica rapaon
cisplatin-induced nephrotoxicity in LLC-PK1cells and
rats. Biol Pharm Bull. 29:2436–2441. 2006.PubMed/NCBI
|
15
|
Satoh M, Kashihara N, Fujimoto S, Horike
H, Tokura T, Namikoshi T, Sasaki T and Makino H: A novel free
radical scavenger, edarabone, protects against cisplatin-induced
acute renal damage in vitro and in vivo. J Pharmacol Exp Ther.
305:1183–1190. 2003. View Article : Google Scholar : PubMed/NCBI
|
16
|
Van Waes C: Nuclear factor-kappaB in
development, prevention, and therapy of cancer. Clin Cancer Res.
13:1076–1082. 2007.PubMed/NCBI
|
17
|
Senderowicz AM: Targeting cell cycle and
apoptosis for the treatment of human malignancies. Curr Opin Cell
Biol. 16:670–678. 2004. View Article : Google Scholar : PubMed/NCBI
|
18
|
Skladanowski A, Côme MG, Sabisz M,
Escargueil AE and Larsen AK: Down-regulation of DNA topoisomerase
IIalpha leads to prolonged cell cycle transit in G2 and early M
phases and increased survival to microtubule-interacting agents.
Mol Pharmacol. 68:625–634. 2005.PubMed/NCBI
|
19
|
Cho JH, Lee JG, Yang YI, Kim JH, Ahn JH,
Baek NI, Lee KT and Choi JH: Eupatilin, a dietary flavonoid,
induces G2/M cell cycle arrest in human endometrial cancer cells.
Food Chem Toxicol. 49:1737–1744. 2011. View Article : Google Scholar : PubMed/NCBI
|
20
|
Castro J, Ribó M, Navarro S, Nogués MV,
Vilanova M and Benito A: A human ribonuclease induces apoptosis
associated with p21WAF1/CIP1induction and JNK
inactivation. BMC Cancer. 11:92011. View Article : Google Scholar : PubMed/NCBI
|
21
|
Kalimutho M, Minutolo A, Grelli S, Formosa
A, Sancesario G, Valentini A, Federici G and Bernardini S:
Satraplatin (JM-216) mediates G2/M cell cycle arrest and
potentiates apoptosis via multiple death pathways in colorectal
cancer cells thus overcoming platinum chemo-resistance. Cancer
Chemother Pharmacol. 67:1299–1312. 2011. View Article : Google Scholar
|
22
|
Huang WW, Ko SW, Tsai HY, Chung JG, Chiang
JH, Chen KT, Chen YC, Chen HY, Chen YF and Yang JS: Cantharidin
induces G2/M phase arrest and apoptosis in human colorectal cancer
colo 205 cells through inhibition of CDK1 activity and
caspase-dependent signaling pathways. Int J Oncol. 38:1067–1073.
2011.
|
23
|
Dia VP and Mejia EG: Lunasin promotes
apoptosis in human colon cancer cells by mitochondrial pathway
activation and induction of nuclear clusterin expression. Cancer
Lett. 295:44–53. 2010. View Article : Google Scholar : PubMed/NCBI
|
24
|
Abbas T and Dutta A: p21 in cancer:
intricate networks and multiple activities. Nat Rev Cancer.
9:400–414. 2009. View
Article : Google Scholar : PubMed/NCBI
|
25
|
Vousden KH and Prives C: Blinded by the
light: the growing complexity of p53. Cell. 137:413–431. 2009.
View Article : Google Scholar : PubMed/NCBI
|
26
|
Chu G: Cellular responses to cisplatin:
The roles of DNA-binding proteins and DNA repair. J Biol Chem.
269:787–790. 1994.PubMed/NCBI
|
27
|
Malugin A, Kopecková P and Kopecek J: HPMA
copolymer-bound doxorubicin induces apoptosis in ovarian carcinoma
cells by the disruption of mitochondrial function. Mol Pharm.
3:351–361. 2006. View Article : Google Scholar : PubMed/NCBI
|
28
|
Yim EK, Lee KH, Bae JS, Namkoong SE, Um SJ
and Park JS: Proteomic analysis of antiproliferative effects by
treatment of 5-fluorouracil in cervical cancer cells. DNA Cell
Biol. 23:769–776. 2004. View Article : Google Scholar : PubMed/NCBI
|
29
|
Boulikas T and Vougiouka M: Cisplatin and
platinum drugs at the molecular level (Review). Oncol Rep.
10:1663–1682. 2003.PubMed/NCBI
|
30
|
Lin JP, Yang JS, Lee JH, Hsieh WT and
Chung JG: Berberine induces cell cycle arrest and apoptosis in
human gastric carcinoma SNU-5 cell line. World J Gastroenterol.
12:21–28. 2006.PubMed/NCBI
|
31
|
Hwang JM, Kuo HC, Tseng TH, Liu JY and Chu
CY: Berberine induces apoptosis through a mitochondria/caspases
pathway in human hepatoma cells. Arch Toxicol. 80:62–73. 2006.
View Article : Google Scholar : PubMed/NCBI
|
32
|
Mantena SK, Sharma SD and Katiyar SK:
Berberine, a natural product, induces G1-phase cell cycle arrest
and caspase-3-dependent apoptosis in human prostate carcinoma
cells. Mol Cancer Ther. 5:296–308. 2006. View Article : Google Scholar : PubMed/NCBI
|
33
|
Kuo CL, Chou CC and Yung BY: Berberine
complexes with DNA in the berberine-induced apoptosis in human
leukemic HL-60 cells. Cancer Lett. 93:193–200. 1995. View Article : Google Scholar : PubMed/NCBI
|
34
|
Vaux DL and Korsmeyer SJ: Cell death in
development. Cell. 96:245–254. 1999. View Article : Google Scholar
|
35
|
Aggarwal BB: Nuclear factor-kappaB: the
enemy within. Cancer Cell. 6:203–208. 2004.PubMed/NCBI
|
36
|
Sun W, Guo MM, Han P, Lin JZ, Liang FY,
Tan GM, Li HB, Zeng M and Huang XM: Id-1 and the p65 subunit of
NF-κB promote migration of nasopharyngeal carcinoma cells and are
correlated with poor prognosis. Carcinogenesis. 33:810–817.
2012.
|
37
|
Zhang Y, Lang JY, Liu L, Wang J, Feng G,
Jiang Y, Deng YL, Wang XJ, Yang YH, Dai TZ, Xie G, Pu J and Du XB:
Association of nuclear factor κB expression with a poor outcome in
nasopharyngeal carcinoma. Med Oncol. 28:1338–1342. 2011.
|
38
|
Gupta S, Hastak K, Afaq F, Ahmad N and
Mukhtar H: Essential role of caspases in
epigallocatechin-3-gallate-mediated inhibition of nuclear factor
kappa B and induction of apoptosis. Oncogene. 23:2507–2522. 2004.
View Article : Google Scholar : PubMed/NCBI
|
39
|
Miyajima A, Nakashima J, Yoshioka K,
Tachibana M, Tazaki H and Murai M: Role of reactive oxygen species
in cis-dichlorodiammineplatinum-induced cytotoxicity on bladder
cancer cells. Br J Cancer. 76:206–210. 1997. View Article : Google Scholar : PubMed/NCBI
|
40
|
Meijer C, Mulder NH, Timmer-Bosscha H,
Zijlstra JG and de Vries EG: Role of free radicals in an
adriamycin-resistant human small cell lung cancer cell line. Cancer
Res. 47:4613–4617. 1987.PubMed/NCBI
|
41
|
Sausville EA, Stein RW, Peisach J and
Horwitz SB: Properties and products of the degradation of DNA by
bleomycin and iron (II). Biochemistry. 17:2746–2754. 1978.
View Article : Google Scholar : PubMed/NCBI
|
42
|
Yamauchi N, Kuriyama H, Watanabe N, Neda
H, Maeda M and Niitsu Y: Intracellular hydroxyl radical production
induced by recombinant human tumor necrosis factor and its
implication in the killing of tumor cells in vitro. Cancer Res.
49:1671–1675. 1989.
|
43
|
Chirino YI and Pedraza-Chaverri J: Role of
oxidative and nitrosative stress in cisplatin-induced
nephrotoxicity. Exp Toxicol Pathol. 61:223–242. 2009. View Article : Google Scholar : PubMed/NCBI
|
44
|
Rybak LP, Whitworth CA, Mukherjea D and
Ramkumar V: Mechanisms of cisplatin-induced ototoxicity and
prevention. Hear Res. 226:157–167. 2007. View Article : Google Scholar : PubMed/NCBI
|
45
|
van den Berg JH, Beijnen JH, Balm AJ and
Schellens JH: Future opportunities in preventing cisplatin induced
ototoxicity. Cancer Treat Rev. 32:390–397. 2006.PubMed/NCBI
|
46
|
Chen GG, Leung J, Liang NC, Li L, Wu K,
Chan UP, Leung BC, Li M, Du J, Deng YF, Gong X, Lv Y, Chak EC and
Lai PB: Ent-11α-hydroxy-15-oxo-kaur-16-en-19-oic-acid inhibits
hepatocellular carcinoma in vitro and in vivo via stabilizing IκBα.
Invest New Drugs. 30:2210–2218. 2012.
|
47
|
Li MY, Leung J, Kong AW, Liang NC, Wu K,
Hsin MK, Deng YF, Gong X, Lv Y, Mok TS, Underwood MJ and Chen GG:
Anticancer efficacy of 5F in NNK-induced lung cancer development of
A/J mice and human lung cancer cells. J Mol Med. 88:1265–1276.
2010. View Article : Google Scholar : PubMed/NCBI
|